Other OTC - Delayed Quote USD

Perimeter Medical Imaging AI, Inc. (PYNKF)

0.4967

-0.0401

(-7.47%)

At close: April 26 at 11:35 AM EDT

Key Events

Loading Chart for PYNKF

9/21 12:03 PM

DELL

Previous Close 0.5368
Open 0.4967
Bid --
Ask --
Day's Range 0.4967 - 0.4967
52 Week Range 0.4967 - 1.5000
Volume 1,800
Avg. Volume 4,528
Market Cap (intraday) 33.338M
Beta (5Y Monthly) 0.97
PE Ratio (TTM) --
EPS (TTM) -0.2200
Earnings Date May 23, 2024 - May 27, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging tools that address unmet medical needs. The company offers Perimeter S-Series optical coherence tomography (OCT) imaging system that delivers resolution margin visualization of excised tissue specimens in the operating room. It also develops Perimeter B-series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.

perimetermed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications

Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications

Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates

Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results

Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results

Perimeter Medical Imaging AI Reports Its Proprietary Artificial Intelligence Algorithm + OCT Identified 96.8% of Positive Breast Cancer Margins in Newly Published Peer Reviewed Study

Perimeter Medical Imaging AI Reports Its Proprietary Artificial Intelligence Algorithm + OCT Identified 96.8% of Positive Breast Cancer Margins in Newly Published Peer Reviewed Study

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costs

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costs

Perimeter Medical Imaging AI Announces Expanded Commercial Presence within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series OCT at Additional Hospital Site

Perimeter Medical Imaging AI Announces Expanded Commercial Presence within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series OCT at Additional Hospital Site

Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider System

Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider System

Perimeter Medical Imaging AI Announces Investor Webinar Featuring Breast Surgeon KOL to Discuss Re-excision Epidemic and Potential Benefits of AI in Cancer Surgery

Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update

Perimeter Medical Imaging AI initiates new clinical trial site in Seattle, WA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

S&P/TSX Composite index

.

YTD Return

PYNKF

47.72%

S&P/TSX Composite index

4.82%

1-Year Return

PYNKF

63.48%

S&P/TSX Composite index

7.48%

3-Year Return

PYNKF

84.03%

S&P/TSX Composite index

15.01%

5-Year Return

PYNKF

175.94%

S&P/TSX Composite index

32.54%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Perimeter Medical Imaging AI, Inc.

0.4967

-7.47%

Mkt Cap 33.338M

Industry Medical Devices

Hamilton Thorne Ltd.

1.0008

+5.66%

Mkt Cap 153.216M

Industry Medical Devices

41.65

+3.74%

Mkt Cap EUR 506.293M

Industry Medical Devices

Vapotherm, Inc.

1.2500

-0.51%

Mkt Cap 7.742M

Industry Medical Devices

0.0999

+16.16%

Mkt Cap 1.195M

Industry Medical Devices

Acutus Medical, Inc.

0.1665

+1.90%

Mkt Cap 4.948M

Industry Medical Devices

Getinge AB (publ)

235.10

+2.57%

Mkt Cap SEK 64.034B

Industry Medical Devices

6.63

+1.69%

Mkt Cap 289.649M

Industry Medical Devices

Sonova Holding AG

257.00

+2.11%

Mkt Cap CHF 15.324B

Industry Medical Devices

Telesis Bio, Inc.

0.3184

-3.89%

Mkt Cap 9.585M

Industry Medical Devices

326.60

+3.29%

Mkt Cap DKK 72.032B

Industry Medical Devices

Valuation Measures

As of 4/26/2024

Market Cap

33.34M
Enterprise Value

19.55M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

79.60
Price/Book (mrq)

2.14
Enterprise Value/Revenue

48.45
Enterprise Value/EBITDA

-1.47

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-36.86%
Return on Equity (ttm)

-68.18%
Revenue (ttm)

644.75k
Net Income Avi to Common (ttm)

-14.04M
Diluted EPS (ttm)

-0.2200

Balance Sheet and Cash Flow

Total Cash (mrq)

13.98M
Total Debt/Equity (mrq)

1.28%
Levered Free Cash Flow (ttm)

-11.9M

PYNKF does not have Company Insights

HTLZF Hamilton Thorne Ltd.

1.0008

+5.66%

ASAPF Aurora Spine Corporation

0.2127

-3.10%

AUMBF 1911 Gold Corporation

0.0673

+4.30%

AVCNF Avicanna Inc.

0.2653

-5.45%

BNXAF Banxa Holdings Inc.

0.4913

+2.40%

DLTNF Delta 9 Cannabis Inc.

0.0165

-9.84%

ADCOF Adcore Inc.

0.1818

0.00%

APLIF Appili Therapeutics Inc.

0.0295

+5.73%

AIMFF Aimia Inc.

1.7325

+1.32%

YOURF YourWay Cannabis Brands Inc.

0.0000

0.00%

EGTYF Eguana Technologies Inc.

0.0090

+25.00%

ROMJF Rubicon Organics Inc.

0.2755

0.00%

DBCCF Decibel Cannabis Company Inc.

0.0965

+4.78%

ANKOF Angkor Resources Corp.

0.0852

0.00%

WBNEF WestBond Enterprises Corporation

0.0900

0.00%

MAKOF Mako Mining Corp.

2.4900

+0.81%